Biosafety Issues-An open access journal

(prHWY.com) January 25, 2013 - Las Vegas, NV -- The biosafety measures concern the use of DNA technologies in boosting the development of hybrid crops and even cross-breed animals. The efforts on biosafety are concentrated around preventing pathogens from spreading indiscriminately across the various realms of the biological and chemical processed conducted by humans.
The OMICS journal of Biosafety sheds light on the latest research findings and updates from the concerned discipline. Recent work in Biosafety has led to practices in research laboratories where certain standards must be followed where tubercle bacilli are manipulated. Primary cultures of clinical specimens infected by M. tuberculosis complex bacilli are carried out in accordance with the Biosafety Level 2 standards.
The extent in terms of biosafety standards at certain laboratories in Spain was realized after a study recorded at 26 mycobacteriology laboratories found less than half of the employees received periodic safety information, while about one-third of the workforce said air-filtering systems were not present in enough number; in addition to absence of negative pressure as a precautionary measure.
A good number of microbiological processes release tiny droplets known as aerosols, whose fine division dictates their path. Smaller droplets containing micro-organisms are transferred into droplet nuclei in the form of dehydrated mass just within a hundredth part of a second. These particles might stay airborne for several hours, and contain M. tuberculosis, along with the constituent droplet particles.
The guidelines for safety of bacteriology and other processes are being updated lately for coming up with more effective safety measures. These include restricting the access of microbiology section to the limited staff only, and a medical waste contract or a decontamination facility should be present. Technology specialists are to be recruited so that proper specimen analysis is done with proper judgment to avoid any kinds of hazards that might affect patients.
Biological risk assessment usually involves five steps, as outlined by experts in the concerned practice. The process starts with identifying the hazards of an infecting material or agent. Activities or processes that might cause exposure to the agent are also identified. The threats are measured against the competencies of the people working in the laboratory. The risks are than evaluated and lined up to be addressed according to priority. Controls are developed to contain the risks and monitor the progress of risk exposure.
Biosafety Levels (BSL) dictates the degree of containment required with respect to the severance or occurrence of any risk. Each of the levels is based on complexity of laboratory practices and techniques in the increasing order, as each level builds on the previous level to for risk containment, that are from 1-4. The primary barriers and secondary barriers are safety equipment and in-built laboratory facilities, respectively.
Simple safety measures include washing hands frequently, and containers of harmful gases should be examined for leakages before being placed in racks, rockers and subjected to close-tube sampling before centrifugation.

The OMICS journals accept articles from the authors and have a dedicated editorial board for peer-review of journals. Articles are accepted prior to publication and should confirm to standards of Open Access and the contemporary scientific publication standards.
The OMICS Publishing Group, based in the US, aims at sharing scientific knowledge by publication of research articles in journals, organizing international conferences, and developing eBooks for free availability of knowledge to the scientific learners and researchers.

###